Kolenko V - Search Results

1

Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer.

Uzzo RG, Brown JG, Horwitz EM, Hanlon A, Mazzoni S, Konski A, Greenberg RE, Pollack A, Kolenko V, Watkins-Bruner D. Uzzo RG, et al. Among authors: kolenko v. BJU Int. 2004 May;93(7):955-60. doi: 10.1111/j.1464-410X.2004.04759.x. BJU Int. 2004. PMID: 15142142

2

Caspase-dependent and -independent death pathways in cancer therapy.

Kolenko VM, Uzzo RG, Bukowski R, Finke JH. Kolenko VM, et al. Apoptosis. 2000 Feb;5(1):17-20. doi: 10.1023/a:1009677307458. Apoptosis. 2000. PMID: 11227486 Review.

3

The T cell death knell: immune-mediated tumor death in renal cell carcinoma.

Uzzo RG, Kolenko V, Froelich CJ, Tannenbaum C, Molto L, Novick AC, Bander NH, Bukowski R, Finke JH. Uzzo RG, et al. Among authors: kolenko v. Clin Cancer Res. 2001 Oct;7(10):3276-81. Clin Cancer Res. 2001. PMID: 11595725

4

Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytes.

Kolenko VM, Uzzo RG, Dulin N, Hauzman E, Bukowski R, Finke JH. Kolenko VM, et al. Apoptosis. 2001 Dec;6(6):419-29. doi: 10.1023/a:1012497926537. Apoptosis. 2001. PMID: 11595831

5

Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents.

Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N, Kolenko VM. Uzzo RG, et al. Clin Cancer Res. 2002 Nov;8(11):3579-83. Clin Cancer Res. 2002. PMID: 12429649

6

The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician.

Uzzo RG, Cairns P, Al-Saleem T, Hudes G, Haas N, Greenberg RE, Kolenko V. Uzzo RG, et al. Among authors: kolenko v. Urol Clin North Am. 2003 Aug;30(3):423-36. doi: 10.1016/s0094-0143(03)00021-1. Urol Clin North Am. 2003. PMID: 12953746 Review.

7

Renal carcinoma cells undergo apoptosis without oligonucleosomal DNA fragmentation.

Yamaguchi K, Uzzo R, Dulin N, Finke JH, Kolenko V. Yamaguchi K, et al. Among authors: kolenko v. Biochem Biophys Res Commun. 2004 Jun 4;318(3):710-3. doi: 10.1016/j.bbrc.2004.04.086. Biochem Biophys Res Commun. 2004. PMID: 15144896

8

Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis.

Yamaguchi K, Uzzo RG, Pimkina J, Makhov P, Golovine K, Crispen P, Kolenko VM. Yamaguchi K, et al. Oncogene. 2005 Sep 1;24(38):5868-77. doi: 10.1038/sj.onc.1208742. Oncogene. 2005. PMID: 15897871

9

Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.

Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM. Uzzo RG, et al. Carcinogenesis. 2006 Oct;27(10):1980-90. doi: 10.1093/carcin/bgl034. Epub 2006 Apr 10. Carcinogenesis. 2006. PMID: 16606632

10

Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention.

Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, Horwitz EM, Greenberg RE, Kolenko VM. Crispen PL, et al. Prostate. 2007 May 1;67(6):582-90. doi: 10.1002/pros.20468. Prostate. 2007. PMID: 17262802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters